Exploring how radical species can improve chemical synthesis for pharmaceuticals
Radical-Mediated Atom-Transfer Strategies for Chemical Synthesis
This study is looking at how certain reactive molecules affect cell growth and diseases, with the goal of finding better ways to make and improve medicines that can help people with health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10645232 on NIH RePORTER |
What this research studies
This research investigates the role of radical species in biological systems, particularly their impact on cell proliferation and disease pathways. By understanding the reactivity of various radical intermediates, the research aims to develop new synthetic methodologies that can enhance the efficiency of existing pharmaceuticals and create new therapeutic tools. The approach involves using phosphorous-based reagents to generate radicals from unconventional precursors, which can lead to the formation of important chemical bonds found in many FDA-approved drugs. This work could ultimately streamline drug development and improve diagnostic and treatment options.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients with conditions that require innovative pharmaceutical treatments or improved diagnostic tools.
Not a fit: Patients with conditions that are not addressed by current pharmaceutical therapies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient drug synthesis and the development of new therapeutics that improve patient outcomes.
How similar studies have performed: Previous research has shown promise in using radical-mediated approaches for drug synthesis, indicating potential for success in this area.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Schmidt, Valerie Anne — University of California, San Diego
- Study coordinator: Schmidt, Valerie Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.